|
|
Biological activity of Peganum harmala L. alkaloids and their semi-synthetic derivatives II.
Fejtková, Martina ; Chlebek, Jakub (advisor) ; Cahlíková, Lucie (referee)
Fejtková Martina: Biological activity of Peganum harmala L. alkaloids and their semi-synthetic derivatives II. Diploma thesis 2022. Charles University, Faculty of Pharmacy in Hradec Králové, Department of Pharmacognosy und Pharmaceutical botany. This diploma thesis deals with the preparation of semi-synthetic derivatives of the alkaloid harmine and the study of their biological activity. The alkaloid harmine was isolated by preparative TLC from an alkaloid extract, exactly from its subfraction PH-F1. Semi-synthetic derivatives were prepared by incorporation of different substituents in the N9 position of harmine. For the purposes of this diploma thesis were prepared 17 derivatives, which were subsequently identified on the basis of LC-MS, ESI-HRMS and NMR analysis. After structural elucidation of prepared derivatives, their biological activity was studied. The prepared substances were tested for their inhibitory effect on human acetylcholinesterase (AChE), human butyrylcholinesterase (BuChE), glykogen synthase kinase 3β (GSK-3β) and their cytotoxic activity was also measured on selected tumor and leukemia lines and one healthy cell line. Some of the prepared derivatives showed interesting selective inhibitory potencial against human BuChE, the most active derivative was...
|
|
|
Phenotypic and functional characterization of leukocytes in patients with immune system dysregulation
Fejtková, Martina
Inborn errors of immunity (IEI) are a heterogenic group of diseases of the immune system causing dysregulations of both innate and adaptive immunity. New altered immune-related genes are discovered every year, nowadays reaching over 400. (Tangye et al., 2020) Here three new autoinflammatory disorders of IEI patients are described. Toll-like receptors (TLR) 7 and 8 are endosomal receptors in the innate immune response against external pathogens and endogenous autoantigens. A dysregulation in TLR7 and TLR8 in mice causes autoimmunity and inflammation, however, in humans, the immunopathology of TLR8 and TLR7 remains unclear. We identified a novel X-linked c.1715G>T mutation in TLR8 that leads to autoimmune haemolytic anaemia and autoinflammation in male twins caused by dysregulation in TLR8 and TLR7 response especially in myeloid cells (low TLR8 protein expression, cross-reactivity of TLR8 for TLR7 ligands and enhanced TLR7 response). Hematopoietic cell kinase (HCK) belongs to the Src family of kinases and is involved in myeloid cell migration, adhesion and degranulation. Kinase activity in the immune response must be strictly regulated. In HCK, this regulation is based on C-terminal inhibitory tyrosine, which when phosphorylated, HCK kinase activity is switched off. We identified a heterozygous...
|
|
|
Phenotypic and functional characterization of leukocytes in patients with immune system dysregulation
Fejtková, Martina ; Kanderová, Veronika (advisor) ; Vlková, Marcela (referee) ; Balounová, Jana (referee)
Inborn errors of immunity (IEI) are a heterogenic group of diseases of the immune system causing dysregulations of both innate and adaptive immunity. New altered immune-related genes are discovered every year, nowadays reaching over 400. (Tangye et al., 2020) Here three new autoinflammatory disorders of IEI patients are described. Toll-like receptors (TLR) 7 and 8 are endosomal receptors in the innate immune response against external pathogens and endogenous autoantigens. A dysregulation in TLR7 and TLR8 in mice causes autoimmunity and inflammation, however, in humans, the immunopathology of TLR8 and TLR7 remains unclear. We identified a novel X-linked c.1715G>T mutation in TLR8 that leads to autoimmune haemolytic anaemia and autoinflammation in male twins caused by dysregulation in TLR8 and TLR7 response especially in myeloid cells (low TLR8 protein expression, cross-reactivity of TLR8 for TLR7 ligands and enhanced TLR7 response). Hematopoietic cell kinase (HCK) belongs to the Src family of kinases and is involved in myeloid cell migration, adhesion and degranulation. Kinase activity in the immune response must be strictly regulated. In HCK, this regulation is based on C-terminal inhibitory tyrosine, which when phosphorylated, HCK kinase activity is switched off. We identified a heterozygous...
|
|
|
Biological activity of Peganum harmala L. alkaloids and their semi-synthetic derivatives II.
Fejtková, Martina ; Chlebek, Jakub (advisor) ; Cahlíková, Lucie (referee)
Fejtková Martina: Biological activity of Peganum harmala L. alkaloids and their semi-synthetic derivatives II. Diploma thesis 2022. Charles University, Faculty of Pharmacy in Hradec Králové, Department of Pharmacognosy und Pharmaceutical botany. This diploma thesis deals with the preparation of semi-synthetic derivatives of the alkaloid harmine and the study of their biological activity. The alkaloid harmine was isolated by preparative TLC from an alkaloid extract, exactly from its subfraction PH-F1. Semi-synthetic derivatives were prepared by incorporation of different substituents in the N9 position of harmine. For the purposes of this diploma thesis were prepared 17 derivatives, which were subsequently identified on the basis of LC-MS, ESI-HRMS and NMR analysis. After structural elucidation of prepared derivatives, their biological activity was studied. The prepared substances were tested for their inhibitory effect on human acetylcholinesterase (AChE), human butyrylcholinesterase (BuChE), glykogen synthase kinase 3β (GSK-3β) and their cytotoxic activity was also measured on selected tumor and leukemia lines and one healthy cell line. Some of the prepared derivatives showed interesting selective inhibitory potencial against human BuChE, the most active derivative was...
|
|
|
Chimeric antigen receptors (CARs) in cancer treatment
Fejtková, Martina ; Macková, Jana (advisor) ; Fraiberk, Martin (referee)
Chimeric antigen receptor (CAR) is an artificial T-lymphocyte receptor consisting of extracellular single chain antibody serving as antigen binding site, transmembrane part and intracellular part which activates the cell. Therefore, it has the advantage of targeted specificity of monoclonal antibody and artificially strengthened activation of the T-lymphocyte by activation and costimulation domains. T-lymphocyte with CAR is able to locate and eliminate target cell with given surface antigen and also activate other compartments of the immune system by cytokine production. CAR T-lymphocytes have a huge potential for treatment of hematomalignancies and research also comes with new achievements in CAR modification for elimination of solid tumors.
|
|
|
Cell signaling aberrations in primary immunodeficiencies
Fejtková, Martina ; Kanderová, Veronika (advisor) ; Vlková, Marcela (referee)
Primary immunodeficiencies (PID) are genetic disorders characterized by increased susceptibility to infections and various degrees of immune dysregulation. With the expansion of massive parallel sequencing, an increasing number of defects in immune-related genes is being identified in PID. However, the biological impact of the found mutations is often unknown. It is necessary to devise methods to clarify their causality for disease development, which may also aid therapeutic decisions. One of the novel discoveries are gain-of-function mutations in STAT1 gene, resulting in chronic mucocutaneous candidiasis. Candidiasis may be ameliorated with antimycotics or with targeted JAK-STAT inhibitor, ruxolitinib. For our patient with a novel mutation in STAT1, we developed a simple test for the detection of phospho-STAT molecules in peripheral blood lymphocytes. The test confirmed the gain-of-function character of the identified mutation and was used to monitor ruxolitinib treatment efficacy. In the second patient, who presented with lymphadenopathy and immunodeficiency, the as yet undescribed mutation in CASP8 was found. We proved its loss-of-function property expressed as reduced caspase-8 and caspase-3 cleavage, impaired cellular apoptosis, and decreased NFB-related signaling. The third patient who...
|
|
|
Cell signaling aberrations in primary immunodeficiencies
Fejtková, Martina ; Kanderová, Veronika (advisor) ; Vlková, Marcela (referee)
Primary immunodeficiencies (PID) are genetic disorders characterized by increased susceptibility to infections and various degrees of immune dysregulation. With the expansion of massive parallel sequencing, an increasing number of defects in immune-related genes is being identified in PID. However, the biological impact of the found mutations is often unknown. It is necessary to devise methods to clarify their causality for disease development, which may also aid therapeutic decisions. One of the novel discoveries are gain-of-function mutations in STAT1 gene, resulting in chronic mucocutaneous candidiasis. Candidiasis may be ameliorated with antimycotics or with targeted JAK-STAT inhibitor, ruxolitinib. For our patient with a novel mutation in STAT1, we developed a simple test for the detection of phospho-STAT molecules in peripheral blood lymphocytes. The test confirmed the gain-of-function character of the identified mutation and was used to monitor ruxolitinib treatment efficacy. In the second patient, who presented with lymphadenopathy and immunodeficiency, the as yet undescribed mutation in CASP8 was found. We proved its loss-of-function property expressed as reduced caspase-8 and caspase-3 cleavage, impaired cellular apoptosis, and decreased NFB-related signaling. The third patient who...
|
|
|
Chimeric antigen receptors (CARs) in cancer treatment
Fejtková, Martina ; Macková, Jana (advisor) ; Fraiberk, Martin (referee)
Chimeric antigen receptor (CAR) is an artificial T-lymphocyte receptor consisting of extracellular single chain antibody serving as antigen binding site, transmembrane part and intracellular part which activates the cell. Therefore, it has the advantage of targeted specificity of monoclonal antibody and artificially strengthened activation of the T-lymphocyte by activation and costimulation domains. T-lymphocyte with CAR is able to locate and eliminate target cell with given surface antigen and also activate other compartments of the immune system by cytokine production. CAR T-lymphocytes have a huge potential for treatment of hematomalignancies and research also comes with new achievements in CAR modification for elimination of solid tumors.
|
guest ::
RSS feed.